SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 23.44 |
Enterprise Value ($M) | 6.12 |
Book Value ($M) | 11.13 |
Book Value / Share | 3.18 |
Price / Book | 2.11 |
NCAV ($M) | 1.40 |
NCAV / Share | 0.40 |
Price / NCAV | 16.72 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -1.85 |
Return on Assets (ROA) | -1.01 |
Return on Equity (ROE) | -2.17 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 1.70 |
Current Ratio | 1.70 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 22.43 |
Assets | 32.16 |
Liabilities | 21.03 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | -42.03 |
Net Income | -41.84 |
Earnings Per Share Basic And Diluted | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -33.03 |
Cash from Investing | -0.43 |
Cash from Financing | 24.50 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13D/A | Versant Venture Capital VI, L.P. | 4.80 | 0.00 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
7,083 | 31,734 | 22.32 | |
3,271 | 28,224 | 11.59 | |
46,765 | 115,828 | 40.37 | |
9,181 | 39,453 | 23.27 | |
(click for more detail) |
Similar Companies | |
---|---|
TLSA – Tiziana Life Sciences Ltd | TNFA – TNF Pharmaceuticals, Inc. |
TNXP – Tonix Pharmaceuticals Holding Corp. | TRAW – Traws Pharma, Inc. |
TSBX – Turnstone Biologics Corp. |
Financial data and stock pages provided by
Fintel.io